Rybelsus 3 mg is the starting dose of oral semaglutide, a once-daily GLP-1 receptor agonist used to help adults with type 2 diabetes control their blood sugar levels
The compounded versions offered by Omzo's network are not FDA-approved as finished products, and the brand makes no claims of equivalence to FDA-approved medications
Its normal to see a big drop in the first month or two (often partly water weight and early fat loss), then encounter slower periods
Semaglutide tips Strength training Rapid weight loss from taking GLP-1 medications like Ozempic and Wegovy can cause a loss of muscle mass, decrease bone density, and lower your metabolic rate
Common step therapy requirements: Trying a lower-cost medication such as phentermine, topiramate, or bupropion/naltrexone (Contrave) Completing a structured weight management program Documenting a minimum period on the step drug with insufficient results Ask your provider to document any previous weight loss attempts in your chart
The combination may support cognitive function during dieting